We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$252M
AUM Growth
-$19.2M
Cap. Flow
-$55.1M
Cap. Flow %
-21.87%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
OPK icon
Opko Health
OPK
+$20.8M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$9.62M
3
LJPC
La Jolla Pharmaceutical Company
LJPC
+$1.17M

Sector Composition

Rank Sector Weight
1 Healthcare 89.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRTX icon
1
Heron Therapeutics
HRTX
$86.3M
$139M 54.99%
5,190,837
– –
LJPC
2
DELISTED
La Jolla Pharmaceutical Company
LJPC
$77.5M 30.77%
2,872,130
-42,840
-1% -$1.17M
BMRN icon
3
BioMarin Pharmaceuticals
BMRN
$11.5B
$9.45M 3.75%
90,215
-92,085
-51% -$9.62M
OPK icon
4
Opko Health
OPK
$921M
– –
-2,475,000
Closed -$20.8M

Similar funds

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
CCA
Checchi Capital Advisers Beverly Hills, California $1.98B AUM 19.17% 1-Year Est. Return
FWTB
First Western Trust Bank Denver, Colorado $1.98B AUM 1.62% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return

Tang Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, Tang Capital Management held 6 positions worth $252M, down 7.1% from $271M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tang Capital Management withdrew a net $55.1M in Q4 2015, closing 1 position and reducing 2 holdings. Its most notable exit was Opko Health, an estimated $20.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 91% a quarter earlier.

  • Tang Capital Management's biggest Q4 2015 reduction was BioMarin Pharmaceuticals, cutting an estimated $9.62M.
  • Tang Capital Management fully exited Opko Health in Q4 2015, selling an estimated $20.8M.
  • Tang Capital Management's ten largest holdings make up 100% of its $252M portfolio in Q4 2015.
  • Tang Capital Management opened 0 new positions and closed 1 in Q4 2015.
  • Tang Capital Management's portfolio value fell 7.1% quarter-over-quarter to $252M.

Based on Tang Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.